Gentex Sets Q4/FY23 Earnings Release for Jan 31, Call Feb 1
Ticker: GNTX · Form: 8-K · Filed: Jan 26, 2024 · CIK: 355811
Complexity: simple
Sentiment: neutral
Topics: earnings-announcement, corporate-event
TL;DR
**Gentex is dropping Q4/FY23 earnings on Jan 31, conference call Feb 1 – get ready for market reaction!**
AI Summary
Gentex Corporation filed an 8-K on January 26, 2024, to announce the date for its fourth quarter and full year 2023 earnings release and conference call. The company will release its financial results after the market closes on Wednesday, January 31, 2024, and host a conference call at 9:30 AM ET on Thursday, February 1, 2024. This matters to investors because it sets the expectation for when they will receive crucial financial performance data, which can significantly impact the stock price.
Why It Matters
This filing is important because it informs investors exactly when Gentex will disclose its latest financial performance, allowing them to prepare for potential stock price movements based on the results.
Risk Assessment
Risk Level: low — This filing is purely administrative, announcing a future event, and does not contain any immediate financial risks or changes.
Analyst Insight
A smart investor would mark January 31 and February 1, 2024, on their calendar to monitor Gentex's earnings release and conference call for key financial insights and potential market reactions.
Key Players & Entities
- GENTEX CORPORATION (company) — the registrant filing the 8-K
- January 26, 2024 (date) — date of the 8-K report
- January 31, 2024 (date) — date of the Q4 and full year 2023 earnings release
- February 1, 2024 (date) — date of the earnings conference call
- 9:30 AM ET (time) — start time of the earnings conference call
Forward-Looking Statements
- Gentex's stock price will likely experience increased volatility around January 31 and February 1, 2024. (GNTX) — high confidence, target: 2024-02-01
- Analysts will issue updated ratings or price targets for GNTX following the earnings release. (GNTX) — medium confidence, target: 2024-02-05
FAQ
What is the purpose of this 8-K filing by Gentex Corporation?
The purpose of this 8-K filing is to announce the date for Gentex Corporation's fourth quarter and full year 2023 financial results release and the subsequent conference call.
When will Gentex Corporation release its fourth quarter and full year 2023 financial results?
Gentex Corporation will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, January 31, 2024.
When is the conference call scheduled to discuss these results?
The conference call to discuss the results is scheduled for 9:30 AM ET on Thursday, February 1, 2024.
What is Gentex Corporation's trading symbol and on which exchange is it registered?
Gentex Corporation's trading symbol is GNTX, and its Common Stock, par value $0.06 per share, is registered on the NASDAQ Global Select Market.
What is the address of Gentex Corporation's principal executive offices?
The address of Gentex Corporation's principal executive offices is 600 North Centennial Street, Zeeland, Michigan 49464.
Filing Stats: 486 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-01-26 08:00:15
Key Financial Figures
- $0.06 — ich registered Common Stock, par value $0.06 per share GNTX NASDAQ Global Select Mar
Filing Documents
- gntx-20240126.htm (8-K) — 25KB
- exhibit99112312023.htm (EX-99.1) — 150KB
- image.jpg (GRAPHIC) — 21KB
- 0000355811-24-000007.txt ( ) — 344KB
- gntx-20240126.xsd (EX-101.SCH) — 2KB
- gntx-20240126_lab.xml (EX-101.LAB) — 24KB
- gntx-20240126_pre.xml (EX-101.PRE) — 12KB
- gntx-20240126_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. (a) On January 26, 2024 , Gentex Corporation issued a news release announcing financial results for the fourth quarter and year ended December 31, 2023. A copy of the news release is attached as Exhibit 99.1 to the Form 8-K. The information in this Form 8-K and the attached Exhibit shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. Section 9. Financial Statements and Exhibits
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibit 99.1 – News Release Dated January 26, 2024 . SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: January 26, 2024 GENTEX CORPORATION (Registrant) By /s/ Kevin C. Nash Kevin C. Nash Its Vice President - Finance and Chief Financial Officer EXHIBIT INDEX 99.1 News Release Dated January 26, 2024